Inhibition of the prostaglandin receptor EP2 following status epilepticus reduces delayed mortality and brain inflammation
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Prostaglandin E2 is now widely recognized to play critical roles in brain inflammation and injury, although the responsible prostaglandin receptors have not been fully identified. We developed a potent and selective antagonist for the prostaglandin E2 receptor subtype EP2, TG6-10-1, with a sufficient pharmacokinetic profile to be used in vivo. We found that in the mouse pilocarpine model of status epilepticus (SE), systemic administration of TG6-10-1 completely recapitulates the effects of conditional ablation of cyclooxygenase-2 from principal forebrain neurons, namely reduced delayed mortality, accelerated recovery from weight loss, reduced brain inflammation, prevention of blood–brain barrier opening, and neuroprotection in the hippocampus, without modifying seizures acutely. Prolonged SE in humans causes high mortality and morbidity that are associated with brain inflammation and injury, but currently the only effective treatment is to stop the seizures quickly enough with anticonvulsants to prevent brain damage. Our results suggest that the prostaglandin receptor EP2 is critically involved in neuroinflammation and neurodegeneration, and point to EP2 receptor antagonism as an adjunctive therapeutic strategy to treat SE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876 · cited 1×
“IL-1β plays critical roles in a variety of cellular events such as cell differentiation, proliferation, and apoptosis, and inhibition of either IL-1β synthesis or its receptor attenuates epileptiform activity in a chronic model of epilepsy (44).”
BackgroundMicroglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543 · cited 1×
“As the resident forms of macrophages in the brain, microglia appear to play a pivotal role in seizure-induced immune responses because activated microglia are a major source of a host of proinflammatory and neurotoxic factors including cytokines, chemokines, free radicals, and prostanoids in injured neuronal tissues (…”
BackgroundThe role of inflammation in CNS injury and disease
Lucas, S., Rothwell, N. J., & Gibson, R. M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706400 · Cited by 1,272 · cited 1×
“Brain inflammation is now recognized as a common feature of chronic neurodegenerative disorders, with the COX-2 cascade being widely believed to play a central role (36, 37).”
BackgroundLiu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095 · cited 1×
“As the resident forms of macrophages in the brain, microglia appear to play a pivotal role in seizure-induced immune responses because activated microglia are a major source of a host of proinflammatory and neurotoxic factors including cytokines, chemokines, free radicals, and prostanoids in injured neuronal tissues (…”
BackgroundHurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811 · cited 1×
“IL-6 is one of themajormediators of both the acute phase and chronic responses during inflammation (46, 47).”
BackgroundBlood-brain barrier leakage may lead to progression of temporal lobe epilepsy
van Vliet, E. A., da Costa Araujo, S., Redeker, S., van Schaik, R., Aronica, E., & Gorter, J. A. (2007) · Brain · doi:10.1093/brain/awl318 · Cited by 775 · cited 2×
“Opening of the blood–brain barrier was demonstrated in humans with epilepsy and rats after seizures by measuring the extravasation of serum albumin into the brain parenchyma (28).”
BackgroundTGF- receptor-mediated albumin uptake into astrocytes is involved in neocortical epileptogenesis
Ivens, S., Kaufer, D., Flores, L. P., Bechmann, I., Zumsteg, D., Tomkins, O., Seiffert, E., Heinemann, U., & Friedman, A. (2007) · Brain · doi:10.1093/brain/awl317 · Cited by 567
Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage
Librizzi, L., Noè, F., Vezzani, A., de Curtis, M., & Ravizza, T. (2012) · Annals of Neurology · doi:10.1002/ana.23567 · Cited by 253 · cited 1×
“However, recent evidence indicates that leukocyte infiltration together with signals via a leaky blood– brain barrier and astrocyte-derived cytokines enhance inflammation in the brain and contribute to epileptogenesis (26, 28, 51), although the immune responses mediated by those infiltrated leukocytes might afford som…”
BackgroundMicroglial EP2 is critical to neurotoxicity from activated cerebral innate immunity
Shie, F., Montine, K. S., Breyer, R. M., & Montine, T. J. (2005) · Glia · doi:10.1002/glia.20220 · Cited by 110
Cited by
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Vezzani, A., Balosso, S., & Ravizza, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0217-x · Cited by 893
Seizure burden is independently associated with short term outcome in critically ill children
Payne, E. T., Zhao, X. Y., Frndova, H., McBain, K., Sharma, R., Hutchison, J. S., & Hahn, C. D. (2014) · Brain · doi:10.1093/brain/awu042 · Cited by 387
Varvel, N. H., Neher, J. J., Bosch, A., Wang, W., Ransohoff, R. M., Miller, R. J., & Dingledine, R. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604263113 · Cited by 357
“Degradation of the BBB can occur after insults to the brain, including seizures (6, 40, 41).”
BackgroundMethodInfluentialSelf-citationvan Vliet, E. A., Aronica, E., Vezzani, A., & Ravizza, T. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12444 · Cited by 259
Peng, B., Xiao, J., Wang, K., So, K.-F., Tipoe, G. L., & Lin, B. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5200-13.2014 · Cited by 255
Metadata
- Authors
- Jiang, J., Quan, Y., Ganesh, T., Pouliot, W. A., Dudek, F. E., & Dingledine, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2013-02-11
- Volume
- 110
- Issue
- 9
- Pages
- 3591-3596
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1974631216
- Cited by
- 165
- References
- 9
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.